Cost-effectiveness of adopting a postoperative delirium risk prediction tool with nonpharmacological delirium prevention interventions for surgical patients
Kosteneffektivität der Einführung eines postoperativen Delir-Risikovorhersagetools mit nichtpharmakologischen Delirpräventionsinterventionen für chirurgische Patient:innen
Age and Ageing · 03.05.2025 · 54 (5)
DOI: 10.1093/ageing/afaf122 ↗Auf einen Blick
Eine Modellierungsstudie in der Schweiz untersuchte PIPRA plus zum Screening vor Delirprävention. Die Einführung war mit niedrigeren Kosten und einem kleinen QALY-Zuwachs verbunden.
Fragestellung
Ist die Einführung von PIPRA plus zum Screening mit anschließenden nichtpharmakologischen Interventionen kosteneffektiv?
Methode
Kosteneffektmodellierung im Schweizer Gesundheitssystem mit Entscheidungsbaum; Daten aus einer prospektiven Vorher-nachher-Studie und weiteren Quellen; probabilistische Sensitivitätsanalyse.
Ergebnisse
Die Kosten lagen um 2898 CHF pro Patient:in niedriger (SD 1050), der Nutzen stieg um 0,01 QALY (SD 0,026). Wahrscheinlichkeit für Kosteneinsparung: 99,7 %; für Kosteneffektivität: 91 %.
Schlussfolgerung der Autor:innen
Die Autor:innen sehen erste Hinweise, dass die Einführung des Risikoscreenings mit risikoarmen Interventionen kosteneffektiv sein könnte.
Kernaussagen
- 2898 CHF geringere Kosten pro Patient:in
- 0,01 QALY Nutzenzuwachs
- 99,7 % Wahrscheinlichkeit für Kosteneinsparung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 13.05.2025. Verfasst von Nicholas Graves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Duke-NUS Graduate Medical School - HSSR, 8 College Road 01-38, 169857 Singapore, Singapore. Hauptthemen laut MEDLINE: Delirium, Decision Support Techniques, Postoperative Complications, Surgical Procedures, Operative. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Themen: Delir
Abstract (Originalsprache)
Background
Postoperative delirium (POD) arises among older surgical patients. Screening followed by prevention efforts are recommended. A risk prediction tool called PIPRA plus has been developed, yet its performance and whether adoption into health services is cost-effective are unknown.
Objective
To estimate the expected change to ‘total costs’ and ‘health benefits’ measured by quality adjusted life years (QALYs) from a decision to adopt PIPRA plus for screening purpose to find at-risk individuals who are then offered nonpharmacological interventions to reduce risks of POD.
Design
Cost-effectiveness modelling study that draws on a range of relevant data sources.
Setting
Swiss healthcare system. Subjects Surgical inpatients aged 60 or older, excluding cardiac and intracranial surgeries.
Methods
A decision tree model was used to capture the events likely to impact on cost and health outcomes. Information was harvested from a prospective before–after study done in Switzerland and augmented with other data. Probabilistic sensitivity analysis was undertaken to reveal the probability that adoption was cost-effective against a stated maximum willingness to pay threshold for decision-making in Switzerland.
Results
Patients in both phases of the study were similar. Costs were lower by 2898 CHF (SD 1050) per patient with the adoption of the risk screening tool and there was a modest gain to health benefits of 0.01 QALY (SD 0.026). There was a 99.7% probability that adoption would be cost-saving and 91% probability that adoption would be cost-effective.
Conclusions
We provide early-stage evidence that a decision to adopt the risk screening tool and offer risk-reducing interventions could be cost-effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke-NUS Graduate Medical School - HSSR, 8 College Road 01-38, 169857 Singapore, Singapore.
- Hirslanden Klinik Hirslanden, Zurich, Switzerland.
- Kusnacht Practice, Geneva, Switzerland.
Zitieren
APA
Graves, N., Böttger, S., Zozmann, M., Franziska, M., & Stocker, R. (2025). Cost-effectiveness of adopting a postoperative delirium risk prediction tool with nonpharmacological delirium prevention interventions for surgical patients. Age and Ageing, 54(5). https://doi.org/10.1093/ageing/afaf122
Vancouver
Graves N, Böttger S, Zozmann M, Franziska M, Stocker R. Cost-effectiveness of adopting a postoperative delirium risk prediction tool with nonpharmacological delirium prevention interventions for surgical patients. Age and Ageing. 2025;54(5). doi:10.1093/ageing/afaf122
BibTeX
@article{Graves2025,
author = {Graves, Nicholas and Böttger, Sönke and Zozmann, Martin and Franziska, Maja and Stocker, Reto},
title = {Cost-effectiveness of adopting a postoperative delirium risk prediction tool with nonpharmacological delirium prevention interventions for surgical patients},
journal = {Age and Ageing},
year = {2025},
volume = {54},
number = {5},
doi = {10.1093/ageing/afaf122}
}
EUVIMED